BioPharmSignal logoBioPharmSignal

Biotech News

Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference

Rapid Micro Biosystems (RPID)Rapid Micro Biosystems2026-06-25 13:46 ESTConference / presentation

LEXINGTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products,

Open original release

Related news

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems Reports First Quarter 2026 Financial Results

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RPIDRapid Micro Biosystems2026-06-25 13:46 EST

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

View all latest news

Rapid Micro Biosystems

Rapid Micro Biosystems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

RPIDZimmer Biomet2026-07-14 12:13 EST

Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

RPIDZimmer Biomet2026-07-13 12:14 EST

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results

RPIDBMYBristol-Myers Squibb Company2026-07-13 10:59 EST

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

RPIDGSK plc2026-07-13 07:00 EST

Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

RPIDMerck2026-07-10 19:01 EST

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)

Stock data

Close
2.01 USD
Market cap
102.13M USD
Exchange
NASDAQ
Sector
Biotechnology
Location
United States